journal article·2026-05Open access

Novel Vascular‐Adaptive Liquid Metal Microspheres Enable Visualized Arterial Embolization Therapy

Chenyu Shen, Junge Chen, Gang Zhang, Zhusheng Liu, Yichen Wan, Lei Lei, Weiyan Ren, Yanyu Zhao, Bozhang Xia, Zhiqiang Yi, Jinjin Wang, Jingwang Gao, Gen Mu, Xing‐Jie Liang, Zhijun Wang

Advanced Science· Volume 13· Issue 30

Abstract

ABSTRACT Arterial embolization therapy is a promising strategy for treating both malignant and benign tumors. However, conventional embolic agents often lack inherent radiopacity and have limited embolizing ability, resulting in difficulty in real‐time monitoring during arterial embolization, low postoperative tumor necrosis rate, and high risk of recurrence. In this study, we prepared a liquid metal microsphere with radiopacity by disrupting the surface tension of liquid gallium via ultrasonication. These microspheres have a self‐limiting oxide layer on their surface, while their core remains liquid. Drug loading can be achieved by modifying the surface of liquid metal microspheres, and the drug‐loaded microspheres are named X‐MEN. Owing to their unique physical structure, these liquid metal microspheres exhibit excellent fluidity, viscoelasticity, and deformability. This enables them to navigate through microcatheters and conform tightly to the vessel wall, achieving efficient embolization. These microspheres can remain stable in the target vessel for at least six months, with no observed recanalization. In addition, the radiopacity of these microspheres allows for real‐time monitoring during arterial embolization, thereby enabling precise control over the embolization process. Therefore, liquid metal microspheres are a very promising long‐acting embolic agent for image‐guided arterial embolization.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hepatocellular Carcinoma Treatment and Prognosis · Nanoplatforms for cancer theranostics · Vascular Malformations Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology of China Beijing China

Department of Geriatric Medicine & National Clinical Research Centre of Geriatric Disease The Second Medical Center Department of Interventional Radiology Chinese PLA General Hospital Beijing China

Tangshan Gongren Hospital Tangshan Hebei China

School of Engineering Medicine Beijing Advanced Innovation Center for Biomedical Engineering School of Integrated Circuit Science and Engineering Beihang University Beijing China

Department of Neurosurgery Peking University First Hospital Beijing China

Bioengineering University of Pennsylvania Philadelphia Pennsylvania USA

Funding

Natural Science Foundation of Beijing Municipality · National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (46)

Show source-provided references
1. 10.1016/j.actbio.2022.07.01910.1016/j.actbio.2022.07.019 ↗
2. 10.1021/acsbiomaterials.3c0065910.1021/acsbiomaterials.3c00659 ↗
3. 10.1002/adma.20190107110.1002/adma.201901071 ↗
4. 10.1016/j.critrevonc.2013.07.00310.1016/j.critrevonc.2013.07.003 ↗
5. 10.7150/thno.3477810.7150/thno.34778 ↗
6. 10.3390/biomedicines1012320210.3390/biomedicines10123202 ↗
7. 10.1016/j.jcis.2009.03.04810.1016/j.jcis.2009.03.048 ↗
8. 10.1016/j.cej.2019.03.22110.1016/j.cej.2019.03.221 ↗
9. 10.1021/acs.iecr.2c0217310.1021/acs.iecr.2c02173 ↗
10. 10.1016/j.jmbbm.2011.08.00110.1016/j.jmbbm.2011.08.001 ↗
11. 10.1007/s10856-010-4080-y10.1007/s10856-010-4080-y ↗
12. 10.1021/acs.iecr.2c0341810.1021/acs.iecr.2c03418 ↗
13. 10.1038/s41467‐023‐41322‐610.1038/s41467‐023‐41322‐6 ↗
14. 10.1016/j.jvir.2008.08.02710.1016/j.jvir.2008.08.027 ↗
15. 10.1007/s00270‐010‐9822‐110.1007/s00270‐010‐9822‐1 ↗
16. 10.3350/kjhep.2011.17.1.5110.3350/kjhep.2011.17.1.51 ↗
17. 10.1002/adhm.20160129110.1002/adhm.201601291 ↗
18. 10.1016/j.colsurfb.2024.11388810.1016/j.colsurfb.2024.113888 ↗
19. 10.1002/smll.20190339110.1002/smll.201903391 ↗
20. 10.1021/acsnano.4c0705110.1021/acsnano.4c07051 ↗
21. 10.1016/j.cej.2024.15019710.1016/j.cej.2024.150197 ↗
22. 10.1021/acsnano.3c0648610.1021/acsnano.3c06486 ↗
23. 10.1002/adfm.20242437010.1002/adfm.202424370 ↗
24. 10.1126/science.adn587110.1126/science.adn5871 ↗
25. 10.1126/science.abm273110.1126/science.abm2731 ↗
26. 10.1038/s41586‐023‐06082‐910.1038/s41586‐023‐06082‐9 ↗
27. 10.1038/s41586‐024‐07339‐710.1038/s41586‐024‐07339‐7 ↗
28. 10.1021/nl202728j10.1021/nl202728j ↗
29. 10.1002/advs.20200019210.1002/advs.202000192 ↗
30. 10.1016/j.matt.2021.11.00610.1016/j.matt.2021.11.006 ↗
31. 10.1016/j.xpro.2022.10182610.1016/j.xpro.2022.101826 ↗
32. 10.1039/C9NR01963D10.1039/C9NR01963D ↗
33. 10.1038/ncomms1543210.1038/ncomms15432 ↗
34. 10.1021/acsnano.1c0157310.1021/acsnano.1c01573 ↗
35. 10.1038/ncomms1006610.1038/ncomms10066 ↗
36. 10.1021/acs.nanolett.6b0434610.1021/acs.nanolett.6b04346 ↗
37. 10.3390/cancers1111166610.3390/cancers11111666 ↗
38. 10.1016/j.biomaterials.2019.03.04310.1016/j.biomaterials.2019.03.043 ↗
39. 10.3390/nano1313201710.3390/nano13132017 ↗
40. 10.1016/j.scib.2023.07.02510.1016/j.scib.2023.07.025 ↗
41. 10.1002/smll.20190342110.1002/smll.201903421 ↗
42. 10.1002/adfm.20220941310.1002/adfm.202209413 ↗
43. 10.1038/s41565‐020‐0693‐610.1038/s41565‐020‐0693‐6 ↗
44. 10.1038/s41551‐022‐00972‐510.1038/s41551‐022‐00972‐5 ↗
45. 10.1126/science.283.5404.96010.1126/science.283.5404.960 ↗
46. 10.1021/acs.molpharmaceut.7b0018810.1021/acs.molpharmaceut.7b00188 ↗